Feb 24, 2025
The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with Recurrent Attacks of Hereditary Angioedema (HAE)
Jan 27, 2025
Neurocrine Biosciences Announces Amendment to Strategic Collaboration with Takeda to Develop and Commercialize Osavampator (formerly NBI-1065845/TAK-653)
Jan 25, 2024
Cognizant Helping to Modernize Infrastructure and Application Management as Part of Takeda's Digital Transformation
Dec 10, 2020
HemoShear Therapeutics Identifies Novel Drug Target to Treat NASH in Drug Discovery Partnership with Takeda
Jun 01, 2020
Despite Increased Competition from the Recent Launch of Janssen's Stelara, Takeda's Entyvio Continues to Shine as a Leading Ulcerative Colitis Treatment
Jun 24, 2019
Global Eating Disorders Markets, 2017-2018 & 2019-2026: Edgemont's Fluoxetine Tablets and Takeda's Vyvanse are the Only FDA-Approved Drugs
May 10, 2019
Europe's Hemostats & Sealants Market by Product & Country 2019-2024 Featuring Baxter, Takeda, Medtronic, C.R Bard, and B Braun
Apr 02, 2019
Motegrity(TM) (prucalopride), the Only Serotonin-4 Receptor Agonist for Adults with Chronic Idiopathic Constipation (CIC), is Now Available in the United States
Mar 26, 2019
US Gastroenterologists Project Near-Term Growth of Takeda's Entyvio and Janssen's Stelara for the Treatment of Crohn's Disease, while Anticipated Increased Adoption of Pfizer's Xeljanz in Ulcerative Colitis is Likely to Interrupt Entyvio's Trajectory
Mar 20, 2019
Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership in Liver Diseases
Jan 14, 2019
Janssen's Stelara and Pfizer's Xeljanz Battle Takeda's Entyvio to Claim the Preferred Alternate Mechanism of Action Position in Inflammatory Bowel Disease Patients Who Are Being Switched from Their Current Treatment
Jul 17, 2018
Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
Nov 17, 2017
The Boston Globe Names Takeda Pharmaceuticals U.S.A., Inc. a Top Place to Work for 2017
Nov 10, 2017
The Chicago Tribune Names Takeda Pharmaceuticals U.S.A., Inc. A Workplace Achiever of the Chicago Area 2017 Top Workplaces Award
Oct 06, 2017
Takeda Donates $100,000 to Local, Regional Charities as Part of Company's Takeda Cares Day Event
Oct 04, 2017
Takeda Welcomes The Honorable Susana Mendoza As Guest Speaker At Deerfield Headquarters To Celebrate Company's Commitment to Latino Culture
Sep 26, 2017
Takeda Named To 2017 Working Mother "100 Best Companies" For Leadership In Family Benefits And Paid Leave
Jul 25, 2017
Takeda and BioSurfaces Announce Joint Research Program to Explore Promising Devices to Treat Gastrointestinal Diseases